Rami Elghandour, Arcellx CEO
Biotech bear market be damned, CAR-T player Arcellx raises $123M IPO
The current biotech bear market doesn’t mean it’s impossible for a new biotech to have a successful IPO, merely harder.
On Friday, CAR-T company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
